REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Simcere Pharmaceutical Group Limited (Nanjing) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Simcere Pharmaceutical Group Limited Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Simcere Pharmaceutical Group Limited focuses on the R&D, production and sales of drugs. The company provides drugs for central nervous system diseases, cancer diseases and autoimmune diseases. The company was established in 2015 and headquartered in Nanjing City, China.

Headquarters
No. 699-18, Xuanwu Road, Xuanwu District
Nanjing; Jiangsu;

Contact Details: Purchase the Simcere Pharmaceutical Group Limited (Nanjing) report to view the information.

Website: http://www.simcere.com

Basic Information
Total Employees:
Purchase the Simcere Pharmaceutical Group Limited (Nanjing) report to view the information.
Outstanding Shares:
Purchase the Simcere Pharmaceutical Group Limited (Nanjing) report to view the information.
Financial Auditors:
Purchase the Simcere Pharmaceutical Group Limited (Nanjing) report to view the information.
Incorporation Date:
November 30, 2015
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
45.85%
Purchase this report to view the information.
23.26%
Purchase this report to view the information.
4.64%
Purchase this report to view the information.
4.3%
Purchase this report to view the information.
Subsidiaries
BCY Pharm Co., Ltd. (China)
100%
Hainan Simcere Pharmaceutical Co., Ltd. (China)
100%
Hainan Yaozhen Biology Medical Technology Co., Ltd. (China)
100%
Company Performance
Financial values in the chart are available after Simcere Pharmaceutical Group Limited (Nanjing) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-7.87%▼
Total operating revenue
-7.83%▼
Operating profit (EBIT)
-49.5%▼
EBITDA
45.94%▲
Net Profit (Loss) for the Period
-79.92%▼
Total assets
-7.7%▼
Total equity
-23.69%▼
Operating Profit Margin (ROS)
-15.35%▼
Net Profit Margin
-52.62%▼
Return on Equity (ROE)
-18.51%▼
Debt to Equity Ratio
3.6%▲
Quick Ratio
-0.2%▼
Cash Ratio
-0.08%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo